NAM KYUNG SENERCHIA: Open Payments
NPI 1497516629 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $261 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Recor Medical Inc | 1 | $27 |
| Amgen Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| CVRx, Inc. | 1 | $17 |
Products named: LEQVIO, VERQUVO, Paradise Ultrasound Renal Denervation System, REPATHA, WATCHMAN Access System, ELIQUIS, JARDIANCE, Barostim Neo System.
Industry payments across VA — which companies pay providers there.
